Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Shareholder vote results
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. ARS Other Annual Report to Security Holders
  9. DEF 14A Proxy Proxy Statement
  10. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $2.89 ($28,887)
  11. 4 Open-market buy Chieve Executive Officer bought 10,000 shares at $2.86 ($28,598)
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. 8-K Event Other events
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 68 · 1,358 filings